Aim: This study was designed to clarify differences in serum phospholipid fatty acid compositions and estimated desaturase activities between Japanese men with and without metabolic syndrome (MetS). Methods: From among 227 males, 40 to 59 years of age, excluding those receiving treatment for lipid disorders, 165 subjects (including 27 with MetS) were selected for this study. Serum phospholipid fatty acid compositions were determined, and desaturase activities were estimated. Results: The C15:0 and C17:0 fatty acids associated with hepatic function were lower, while the C20:3n-6 and C20:4n-3 fatty acids were higher, in subjects with than without MetS (p 0.05). The estimated desaturase activity for D5D(n-6) was lower in subjects with than without MetS (p 0.01). Body fat percentage was an independent negative predictor of C17:0, and a positive predictor of log C20:3n-6 and log C20:4n-3 (p 0.01). HDL-C was an independent negative predictor of log C15:0 and of C17:0 (p 0.01). Conclusion: Decreases in minor saturated fatty acids, accumulation of C20:3n-6 and C20:4n-3 and low estimated D5D activitiy were confirmed to be associated with MetS. 
Introduction
Metabolic syndrome (MetS) has been recognized as a constellation of multiple risk factors for cardiovascular disease, with dyslipidemia plus elevated glucose and blood pressure, which are widely regarded as targets for preventing the early stages of coronary artery disease. The predominant underlying risk factor is considered to be visceral obesity causing insulin resistance 1) . There have been numerous reports on the rela-activity on the risk of ischemic heart disease are unknown. D6D is a rate-limiting enzyme in the PUFA biosynthetic pathway, converting the essential fatty acids linoleic (C18:2n-6) and alpha-linolenic (C18:3n-3) acid into gamma-linolenic acid (C18:3n-6) and octadecatetraenoic acid (C18:4n-3), respectively. According to in vitro and animal model studies, dietary PUFA reportedly decreases both the activity and the expression of D5D and D6D [12] [13] [14] . Stearoyl CoA desaturase (SCD) is also a rate-limiting enzyme catalyzing the synthesis of monounsaturated fatty acids, mainly palmitoleic (C16:1) and oleic (C18:1) acid, from the saturated fatty acids palmitic (C16:0) and stearic (C18:0) acid, respectively. SCD is known to be related to obesity and insulin resistance 11) . The fatty acid composition of serum phospholipids reflects dietary fatty acid intake over the prior few weeks, as well as endogenous fatty acid metabolism 15, 16) . Thus, phospholipids play various important roles not only as membrane components, but also as the source of fatty acids, serving as precursors for physiologically active substances affecting cell functions.
Fatty acid compositions and desaturase activities in Japanese subjects with MetS have not been documented, and habitual dietary fatty acid intake in Japan differs from that in Northern European populations. The purpose of this study was to examine differences in serum phospholipid fatty acid compositions and estimated desaturase activities between Japanese subjects with and without MetS.
Subjects and Methods

Subjects
The protocol was approved by Japan Women's University ethics committee. The 227 male subjects, ranging in age from 40 to 59 years, received a complete medical check-up at Mitsui Memorial Hospital, and provided written informed consent. Subjects receiving treatment for MetS or related disorders were excluded. Thus, data on 165 males were analyzed for this study. According to the definition of the Japanese Committee for the Diagnostic Criteria of Metabolic Syndrome (April 2005) 17) , we defined MetS as the presence of 2 or more abnormalities involving serum lipids, glucose levels and blood pressure in addition to visceral obesity (umbilical circumference: 85 cm or more in men). The following were considered to be abnormal values: Triglyceride (TG) 150 mg/dL and/ or HDL-cholesterol (HDL-C) 40 mg/dL, systolic blood pressure 130 mmHg and/or diastolic blood pressure 85 mmHg, fasting glucose 110 mg dL.
Anthropometric Measurements
Height and weight were measured, and body mass index (BMI) was calculated as: BMI body weight (kg)/ height (m) 2 . Umbilical circumference was measured during the late exhalation phase in the standing position. Body weight and fat percentage were measured using bioelectrical impedance analysis at both heels (Body Fat Analyzer TBF-210, Tanita Co. Ltd, Tokyo). Blood pressure was measured using an automatic blood pressure manometer (Kentaro BP-203RV B, Nihon Colin Co. Ltd, Tokyo), with the subject in the seated position.
Blood Sampling and Analysis
All serum and plasma samples were obtained in the fasting state and measurements were conducted in the laboratory of Mitsui Memorial Hospital. Serum total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-C and TG levels were measured enzymatically. Aspartate aminotransferase (AST), alanine aminotrans- ferase (ALT) and gamma-glutamyltransferase ( -GTP) were measured by UV and L--glutamyl-3-carboxy-4-nitroanilide substrate methods. Uric acid was determined by the uricase method. These biochemical parameters were measured with a TBA-200FR (Toshiba Medical Co. Ltd., Tokyo, Japan). Plasma glucose was determined enzymatically using a fully automated glucose analyzer (GA-1170 Arkray, Inc., Kyoto, Japan) and HbA1c was determined with a fully automated glycohemoglobin (HbA1c) analyzer based on high performance liquid chromatography (HPLC) (ADAMS A1c, HA-8150 Arkray, Inc., Kyoto, Japan). Serum insulin was determined by chemiluminescence immunoassay with an automated immunoassay system, the ADVIA Centaur (Bayer Medical, NY, USA). The homeostasis model assessment for insulin resistance (HOMA-IR) was calculated as: HOMA-IR fasting plasma glucose (mg/dL) fasting insulin (IRI) ( U/L) 405.
Fatty Acid Analysis
Serum lipids were extracted by the method of Folch et al. 18) . The phospholipid (PL) fraction was obtained with thin-layer chromatography and methylated as described in our previous report 19) with minor modifications. The fatty acid methyl esters were separated by gas-liquid chromatography (Shimadzu GC14B, Tokyo, Japan) using a 0.25 mm 30 m capillary column containing DB-FFAP (J&W Scientific, CA, USA). The injector temperature was 230 , and the column temperature rose 2 /min from 160 to 200 . Nitrogen was employed as the carrier gas, and the split ratio was 22.0.
Estimation of Desaturase Activities
Desaturase activities were estimated as the product to precursor ratio of individual fatty acids in serum phospholipids, as follows: SCD(n-7) (C16:1n-7/C16: 0), SCD(n-9) (C18:1cis n-9/C18:0), D5D(n-6) (C20:4n-6/C20:3n-6), D6D(n-3) C18:4n-3/C18: 3n-3, D5D(n-3) (C20:5n-3/C20:4n-3).
Statistical Analysis
Statistical analysis was performed using the SPSS12.0J software package for Windows (SPSS Inc., Japan). Data are expressed as the means standard deviation. Between-group comparisons were made using the Mann-Whitney U test. P values 0.05 were considered significant. Normality was assessed by the Kolmogorov-Smirnov test and skewed variables were log transformed. For all subjects, relations between variables were assessed by linear correlation analysis.
Step- 
Results
Prevalence of Metabolic Syndrome
The prevalence, in our 165 subjects, of an abnormally large umbilical circumference, high blood pressure, abnormal fasting plasma glucose, low HDL-cholesterolemia and hypertriglyceridemia was 76 (46%), 90 (55%), 17 (10%), 11 (7%) and 48 (29%), respectively. The prevalence of MetS in these subjects was 16.3% (27 cases).
Clinical Characteristics
The clinical characteristics of the subjects with and without MetS are shown in Table 1 . In addition to the parameters indicative of MetS, body fat percentage, fasting insulin, HOMA-IR (p 0.001), ALT, uric acid (p 0.01) and HbA1c (p 0.05) were higher in subjects with than without MetS. The TG/HDL-C ratio was also higher in subjects with MetS (p 0.001).
Fatty Acid Composition
Serum phospholipid fatty acid compositions are shown in Table 2 . C15:0 and C17:0 fatty acids were lower, and C20:3n-6 and C20:4n-3 fatty acids higher in subjects with than without MetS (p 0.05).
Multiple Regression Analysis
The best predictors of fatty acid variations differing significantly between subjects with and without Mets, demonstrated by stepwise regression analysis of biological parameters, are shown in Table 3 . Body fat percentage was an independent negative predictor of C17:0, and a positive predictor of log C20:3n-6 and log C20:4n-3 (p 0.01). HDL-C was an independent negative predictor of log C15:0 (p 0.05), and C17:0 (p 0.01). Log TG was an independent negative predictor of C17:0, and a positive predictor of log C20: 3n-6 (p 0.05). -GTP was an independent negative predictor of log C15:0 (p 0.01). Significant independent explanatory variables were obtained; however, the adjusted R 2 values showed a contribution of less than 15% for each fatty acid. Thus, no independent relation of blood pressure or glycemic parameters was observed with any fatty acids.
Estimated Desaturase Activity
As shown in Table 4 , the estimated desaturase activity of D5D(n-6) was lower in subjects with than without MetS (p 0.01). 
Correlations Among Estimated Desaturase Activities
Associations among estimated desaturase activities are shown in Table 5 . There was a positive correlation between SCD(n-7) and SCD(n-9) (p 0.01). Log D6D(n-3) showed negative correlations with SCD(n-7) and SCD(n-9) (p 0.01). Log D5D(n-6) showed a positive correlation with log D5D(n-3) (p 0.01).
Discussion
To our knowledge, this is the first study to determine phospholipid fatty acid compositions and to estimate desaturase activities in Japanese men with MetS. The number of subjects is semi-epidemiological, as those with MetS in the present study received no medications or other treatments, such that the information obtained was unbiased. The prevalence of MetS in our subjects was essentially the same as that in the Japanese adult male population as a whole, i.e. approximately 15% 20, 21) . There have been numerous studies on serum fatty acids and coronary heart disease or atherogenic risk factors, although few focused on C15:0 and/or SCD-1(n-7) C16:1(n-7)/C16:0, SCD-1(n-9) C18:1cis(n-9)/C18:0, D5D(n-6) C20:4(n-6)/C20:3(n-6), D6D(n-3) C18:4(n-3)/ C18:3(n-3), D5D(n-3) C20:5(n-3)/C20:4(n-3). Table 5 . Correlation coefficients between estimated desaturase activities SCD(n-7) SCD(n-9) log D5D(n-6) log D6D(n-3) log D5D(n-3) SCD(n-7) SCD(n-9) log D5D(n-6) log D6D(n-3) log D5D(n-3) 0.641 0.477 0.530 0.635 n 165, Values are significant correlation coefficients at p 0.01 ( ). SCD(n-7) C16:1(n-7)/C16:0, SCD(n-9) C18:1cis(n-9)/C18:0, D5D(n-6) C20:4(n-6)/C20:3(n-6), D6D(n-3) C18:4(n-3)/C18:3(n-3), D5D(n-3) C20:5(n-3)/C20:4(n-3).
C17:0 results 7, 10, 22) . C15:0 and C17:0 are contained in various plant and animal foods but only in small amounts. The percentages of C15:0 and C17:0 in adipose tissue and serum lipid esters have been proposed as biomarkers of dietary ruminant fat intake, especially dairy products 23) , because the human body is unable to synthesize fatty acids with an uneven number of C atoms, unlike ruminal microbes of dairy cattle 24) . In this study, the levels of C15:0 and C17:0 were lower than in Western subjects who probably consume more animal fat and less fish oil; therefore, the results might partially reflect habitual dietary consumption. As no reports have been published on C15:0 and C17:0 fatty acid consumption in Japanese subjects, dietary reports designed to clarify the differences between those with and without MetS are now being investigated.
In MetS subjects, the percentages of C15:0 and C17:0 in phospholipids were lower than in subjects without MetS. Furthermore, C17:0 correlated negatively with HDL-C, body fat percentage and log TG, and is suggested to reflect fat storage and decreased effects of hepatic triglyceride lipase 25) . Warensjö et al. reported that the proportions of C15:0 and C17:0 in serum phospholipids were significantly and negatively correlated with serum concentrations of plasminogen activator inhibitor-1, tissue-type plasminogen activator, TG, insulin, specific insulin, pro-insulin and leptin, suggesting negative relationships with insulin-resistance syndrome and the risk of coronary heart disease; however, they did not measure HDL-C 26) . The mechanisms underlying these results have not been elucidated. Considering that C17:0 is a metabolite converted from PGH1, 8-iso-PGH, 13(S)-hydroxy-PGH2 and 15-keto-PGH2 by human platelet thromboxane synthase 27) , further studies are needed to clarify the role of these minor saturated fatty acids in metabolism, and the involvement of decreased C15:0 and C17:0 in MetS.
One of the two rate-limiting steps in the production of biologically important PUFA, such as C20: 4n-6, C20:5n-3 and C22:6n-3, is the desaturation of C20:3n-6 to C20:4n-6 and C20:4n-3 to C20:5n-3, determined by the activity of D5D. The other step, catalyzed by D6D, is the desaturation of C18:2n-6 to C18:3n-6 and C18:3n-3 to C18:4n-3.
As no data are available on the n-3 biosynthetic pathway in populations consuming fish and fish products daily, we aimed to clarify the significance of the PUFA level and to estimate desaturase activity in Japanese. We showed C20:3n-6 and C20:4n-3 fatty acid levels to be higher and estimated D5D(n-6) activity to be lower in our subjects with than in those without MetS. Essentially the same results were reported for n-6 fatty acids and D5D(n-6) by Zak et al. in the Czech Republic 28) and by Warenjö et al. in a Swedish 10) study population. We were not able to detect C18:3n-6, although its identification has been described in European reports. This was considered to be because of the difference in dietary n-6 and n-3 PUFA intake. Our subjects consumed fish and fish products 9.7 5.0 times per week, and Japanese people generally consume about 90 g of fish and fish products per day 29) . Thus, a lower level of n-6 PUFAs and higher n-3 PUFA percentages were obtained in our subjects than is Western surveys. In addition, our results indicate that despite significantly higher C20:4n-3 fatty acid levels, the estimated D5D(n-3) activity did not differ between our subjects and those without MetS. As for the large intake of C20:5n-3 from fish and fish products, estimated D5D(n-3), calculated as C20:4n-3/ C20:5n-3, does not precisely reflect the n-3 fatty acid biosynthetic state. Therefore, we should take into account the effects of dietary n-3 fatty acid intake when evaluating the appropriateness of the estimated D5D(n-3) activity. The C20:4n-3 fatty acid percentage might be a better parameter than the estimated D5D(n-3) activity for evaluating abnormal n-3 fatty acid synthesis.
Nevertheless, C20:3n-6 and C20:4n-3 fatty acid levels were higher and the estimated D5D(n-6) activity was lower in our subjects with than without MetS. Furthermore, weak but positive relationships were observed between the body fat percentage and log C20:3n-6 and log C20:4n-3. These results are similar to those obtained in obese children with a significantly elevated correlation between plasma C20:3n-6 and leptin 30) . These observations are supported by a report describing a negative correlation between C20:3n-6 and peripheral insulin sensitivity 31) , as well as high SCD and D6D activities and low D5D activity, generally considered to be associated with an insulin-resistant status 32, 33) . SCD-1 expression has been found to be highly correlated with liver steatosis 34) . Under lipogenic conditions, when increased expression of hepatic PPAR 2 lead to elevated SCD, and SREBP-1 was activated with increased insulin resistance and hyperinsulinemia [35] [36] [37] , newly synthesized fatty acids could be dominated by saturated or monounsaturated fatty acids and the availability of essential fatty acids might be limited. The negative correlation between SCD and D6D(n-3) indicates an augmenting reaction which maintains essential PUFA levels. In this study, estimated SCD did not differ between subjects with versus without MetS, and ALT was significantly higher, although within the normal range, in the MetS group. This indicates that in our MetS group, the degree of hepatic steatosis is modest, although lipogenesis might be accelerated. Because of the higher consumption of fish and fish products by Japanese, n-3PUFA levels may still be within the normal range in subjects with Mets, possibly contributing to high C20:3n-6 and C20:4n-3 fatty acids via low D5D expression and/or activity, instead of increased SCD, since dietary PUFA reportedly decreases both the activity and expression of D5D and D6D [12] [13] [14] . The other reasons for increased these fatty acids are the high biochemical use of C20:4n-6 with less use of C20:3n-6. PUFA play important roles as precursors of eicosanoids, such as prostaglandins (PG), thromboxanes and leukotrienes, which help regulate blood pressure, heart rate, vascular dilation, blood clotting, lipolysis and immune responses. C20:3n-6 is the precursor of series 1 PG, such as PGG1, PGH1 and PGE1, which have anti-atherogenic functions. As the percentage of C20:4n-6 did not differ between subjects with and without MetS, we consider phospholipase A2 activity, which generates platelet activating factor (PAF) and PAF-like phospholipids with release of C20:4n-6, to have been accelerated. PAF-like phospholipids are recognized in the atherogenic lipoproteins of small, dense LDL [38] [39] [40] [41] . Zak et al. reported that the severity of MetS was associated with the progression of oxidative stress, as evaluated with conjugated dienes in LDL 28) . Their results are consistent with the high TG/HDL-C ratio in our subjects with compared to without MetS. We have found a TG/HDL-C ratio higher than 2.0 to be an easily measured parameter which indicates the presence of small, dense LDL in first-stage screening 42) .
In conclusion, fatty acid compositions and estimated desaturase activities were confirmed to differ between Japanese male subjects with and without MetS, as in other study populations. Further study is needed to clarify whether altered fatty acid compositions are associated with MetS with atherogenic and thrombogenic mechanisms. The effects of dietary fatty acid intake must also be examined.
